Monday March 25, 2019 13:19

Food and Healthcare Press Releases

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared Heathcare—25 Mar 19

Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia(R) (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for HbA1c reductions at 26 weeks was not confirmed. Presented today at the

Heathcare—21 Mar 19

Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Heathcare—20 Mar 19

Merck and Pfizer Inc. (NYSE: PFE) today announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating the efficacy and safety of avelumab in combination with chemotherapy followed by maintenance therapy of avelumab in

UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Heathcare—20 Mar 19

Today on World Oral Health Day (WOHD), FDI World Dental Federation (FDI) released the results of a survey from 13 countries, which asked parents with children aged 5–16 if their child's school provided lessons on good oral care. Poor oral health

Merck Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Heathcare—15 Mar 19

- Collaboration agreement enables Merck access to Iktos AI technology across three drug discovery projects - Generative modelling AI technology enables rapid and cost-effective design of novel drugs - Agreement is part of Merck's R&D strategy to

Oxford Nanopore Launches Flongle for Rapid, Smaller DNA/RNA Sequencing Tests in Any Heathcare—13 Mar 19

Oxford Nanopore has today made Flongle starter packs available to purchase https://store.nanoporetech.com/flongle.html, after initial testing in an early-access programme. Flongle introduces a new paradigm of smaller, on-demand DNA or RNA sequencing

FDI: Endodontics White Paper Calls for Treatment to Consider Impact on Patient Health and Heathcare—11 Mar 19

FDI World Dental Federation (FDI) released its first white paper on endodontic care today, providing an important resource for dentists, national dental associations (NDAs) and other oral health actors. (Logo:

MLP CARE Completed the Year With Growth Above Expectations in 2018 Heathcare—08 Mar 19

MLP Sagl?k Hizmetleri A.S. ("MLP Care") (BIST: MPARK), the leading private healthcare service provider in Turkey, today announces its financial results for the full year ended December 31, 2018. (TL millon) 2018 2017

Elsevier Launches Assessment Capabilities on Its All-new ClinicalKey Student Heathcare—08 Mar 19

ClinicalKey Student equips medical faculty and students with the resources they need to enhance the teaching and learning experience Elsevier, the information analytics business specializing in science and health, announced today the launch of new

MRT invite to free health check in M Care activity Heathcare—06 Mar 19

Bangkok Expressway and Metro Public Company limited (BEM) invite MRT passengers to free health check in "M Care" activity with famous hospitals at the event such as Traditional Chinese Medicine, Thai Traditional Medicine, Conventional Medicine and

Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Heathcare—05 Mar 19

- Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects - Marks company's 13th CRISPR patent overall - Actively licensing CRISPR-related patents to interested parties Merck, a leading science and

Ozempic(R) Superior in Lowering Blood Sugar and Weight Vs Placebo, Both in Combination with SGLT-2 Heathcare—05 Mar 19

Novo Nordisk today announced publication of results from the SUSTAIN 9 Phase 3b trial in The Lancet Diabetes & Endocrinology. The objective of this 30 week trial was to assess the efficacy and safety of Ozempic(R) (semaglutide) 1.0 mg when added to

Candela Unveils New Corporate Identity at the 2019 American Academy of Dermatology (AAD) Annual Heathcare—04 Mar 19

Syneron-Candela, a leading global medical aesthetic device company, announced today that it has rebranded the company to Candela and will be unveiling new corporate branding at the American Academy of Dermatology (AAD) Annual Meeting in Washington D.C,

Galderma: New Data Reveals Benefits of Combining Oral and Topical Treatment in Patients With Severe Heathcare—04 Mar 19

First randomized clinical trial comparing the efficacy and safety of combined doxycycline 40 mg modified release (DMR) and ivermectin 1% cream (IVM), versus ivermectin 1% cream plus placebo in adults with severe papulopustular rosacea, reveals more than

MED-EL Study Shows That a Quarter of Adults Have Never Had Their Hearing Heathcare—01 Mar 19

BRITS are the worst in the world for having their hearing tested, a major study reveals. Almost half (46%) have NEVER had their ears checked, compared to just 11% in Russia and 19% in the US. In an international study of 11,000 adults across the globe,

INC: Cashews May Have Fewer Calories Than Previously Thought - New Scientific Heathcare—28 Feb 19

In a human-intervention trial published recently in the journal Nutrients, researchers at the USDA, ARS, Beltsville Human Nutrition Research Center, looked at the available energy content in cashew nuts[1]. (Logo: